What Are Kratom Alkaloids? A Full Breakdown of Every Active Compound

Kratom (Mitragyna speciosa) is a tropical evergreen tree native to Southeast Asia, including Thailand, Malaysia, Indonesia, Myanmar, and Papua New Guinea. The plant belongs to the Rubiaceae family, the same botanical family that includes coffee. For centuries, communities in its native regions have used the leaves for traditional purposes. In recent years, kratom has gained widespread attention in scientific literature, regulatory discussions, and consumer markets, largely because of its complex and chemically rich profile of naturally occurring alkaloids.

This article provides a research-based educational overview of the alkaloids identified in kratom leaves. It does not offer medical advice, does not suggest kratom for any health condition, and does not make claims about safety or effectiveness. The information here is intended for readers who want to understand the chemistry of the plant from a scientific standpoint.

What Alkaloids Are?

Alkaloids are a broad class of naturally occurring organic compounds that contain at least one nitrogen atom. They are found across thousands of plant species and are well known for their pharmacological activity in biological systems. Familiar examples of alkaloids in everyday plants include caffeine in coffee, theobromine in cacao, nicotine in tobacco, and quinine in cinchona bark. In kratom, alkaloids are the primary class of compounds that researchers study when investigating the plant's chemistry.

Mitragyna speciosa contains a particularly diverse alkaloid profile. Scientific analysis has identified more than 40 distinct alkaloids in the leaves, although only a smaller subset are present in significant concentrations. The exact composition varies based on the strain, geographic origin, leaf maturity, harvest season, and processing methods.

How Alkaloids Are Classified Within Kratom

The alkaloids in kratom are generally grouped into a few structural classes. Most belong to the indole and oxindole alkaloid families, which are recognized for their characteristic ring structures. Researchers commonly separate kratom alkaloids into two practical categories, the major alkaloids that appear in the largest proportions and the minor alkaloids that appear in trace amounts but still contribute to the chemical fingerprint of the leaf.

The following sections cover the most studied major alkaloids first, followed by an overview of the minor alkaloids.

The Major Alkaloids in Kratom

Mitragynine

Mitragynine is the most abundant alkaloid found in kratom leaves. Depending on the source, it can make up roughly 40 to 66 percent of the total alkaloid content. It is an indole alkaloid that has been the subject of the largest body of scientific research on the plant. Most laboratory and pharmacological studies on kratom focus on mitragynine because of its dominant presence and its interaction profile in preclinical models. Researchers have studied its receptor binding behavior, metabolic pathways, and chemistry. It is important to note that the U.S. Food and Drug Administration has not approved mitragynine for any medical use.

7-Hydroxymitragynine

7-Hydroxymitragynine, often abbreviated as 7-OH, is present in much smaller quantities than mitragynine. It typically accounts for less than two percent of the total alkaloid content and is sometimes found in concentrations below 0.05 percent in fresh leaves. It is structurally similar to mitragynine but differs by the presence of a hydroxyl group at the seventh carbon position. 7-Hydroxymitragynine is one of the most researched minor compounds in kratom because of its distinct chemical behavior in laboratory settings. As with mitragynine, it has not been approved by the FDA for any therapeutic application.

Speciogynine

Speciogynine is a diastereomer of mitragynine, meaning the two compounds share the same molecular formula but have a different three-dimensional arrangement of atoms. Speciogynine usually represents around six to seven percent of the total alkaloid content. It belongs to the same corynantheidine-type indole alkaloid group as mitragynine, and it has been studied for its smooth muscle activity in preclinical models.

Paynantheine

Paynantheine is typically the second or third most abundant alkaloid in kratom, often making up about eight to nine percent of the total alkaloid content. It is also a corynantheidine-type indole alkaloid and is structurally related to mitragynine. Researchers consider paynantheine an important chemical marker for identifying the species and verifying the authenticity of kratom samples.

Speciociliatine

Speciociliatine is another diastereomer of mitragynine, generally present in concentrations of about one percent. It has been examined in pharmacological studies, often in comparison with mitragynine and paynantheine, to understand how subtle structural differences influence chemical behavior.

The Minor Alkaloids in Kratom

The following compounds are present in smaller quantities, often less than one percent of total alkaloid content. While their concentrations are low, they contribute to the chemical complexity of the plant and are documented in phytochemical literature.

Mitraphylline

Mitraphylline is an oxindole alkaloid found in several Mitragyna and Uncaria species. It has been studied in laboratory settings for its general biochemical behavior. In kratom, mitraphylline is present in trace amounts.

Isomitraphylline

Isomitraphylline is the stereoisomer of mitraphylline. Like its counterpart, it is found in trace quantities and contributes to the broader oxindole alkaloid profile of the plant.

Mitragynine Pseudoindoxyl

Mitragynine pseudoindoxyl is a rearranged derivative of mitragynine. It is not typically found in significant quantities in fresh kratom leaves but can form through oxidation or storage. It is studied largely as a chemical curiosity and reference compound in alkaloid research.

Corynantheidine

Corynantheidine, also known as rauhimebine, is a related indole alkaloid present in small concentrations. It is structurally similar to mitragynine and has been used in research as a comparative reference compound for understanding receptor interactions in laboratory models.

Mitraciliatine

Mitraciliatine is another diastereomer related to mitragynine and speciociliatine. It is present in low concentrations and is part of the broader family of corynantheidine-type alkaloids in the plant.

Ajmalicine

Ajmalicine, sometimes called raubasine, is an indole alkaloid found in several plant species, including kratom and Rauwolfia serpentina. In kratom, it is typically present in trace amounts. It has a long history of study in pharmacological research generally, although in kratom its low concentration limits its overall contribution to the leaf's chemistry.

Akuammigine

Akuammigine is a heteroyohimbine alkaloid that has been identified in kratom in trace amounts. It is closely related to mitragynine in structure and is sometimes mentioned in detailed phytochemical analyses of the plant.

Tetrahydroalstonine

Tetrahydroalstonine is another heteroyohimbine alkaloid found in trace quantities. It is more commonly associated with other plants such as Alstonia and Rauwolfia species but has also been detected in kratom samples.

Corynoxine A and Corynoxine B

Corynoxine A and corynoxine B are oxindole alkaloids that appear in low concentrations in kratom leaves. They are also found in related plant species and are sometimes referenced in studies focused on the broader oxindole alkaloid family.

Isocorynoxeine and Corynoxeine

Isocorynoxeine and corynoxeine are additional oxindole alkaloids documented in Mitragyna speciosa. They are present in small amounts but are part of the comprehensive alkaloid fingerprint that researchers use to characterize the plant.

9-Hydroxycorynantheidine

9-Hydroxycorynantheidine is a hydroxylated derivative of corynantheidine. It is found in small quantities and is studied alongside the other corynantheidine-type alkaloids in chemical analysis.

Speciofoline

Speciofoline is one of the lesser studied alkaloids in kratom and is present in trace concentrations. It is included in the comprehensive phytochemical profile of the plant.

Rhynchophylline and Isorhynchophylline

Rhynchophylline and isorhynchophylline are oxindole alkaloids more commonly associated with Uncaria species but have been detected in kratom in trace amounts. They are widely discussed in plant chemistry literature in general.

Hirsutine

Hirsutine is another alkaloid that appears in small quantities. Like several others on this list, it is more abundant in related plants but contributes to the overall alkaloid signature of kratom.

Stipulatine

Stipulatine is a less common alkaloid in kratom and is present in trace amounts. It is one of many minor compounds identified during detailed chromatographic analyses.

Other Trace Alkaloids

Phytochemical studies have continued to identify additional minor and trace alkaloids in Mitragyna speciosa. Examples include isospeciofoline, isopaynantheine, mitragynaline, corynantheidaline, mitralactonine, and others. Many of these compounds are present in extremely small concentrations and are studied primarily within academic and analytical chemistry contexts.

Also Read: Difference Between Mitragynine and 7-hydroxymitragynine

How Alkaloid Concentrations Vary?

The alkaloid profile of kratom is not fixed. It varies based on several factors. Geographic origin plays a role, with leaves harvested in different countries and regions showing different relative concentrations of mitragynine, paynantheine, speciogynine, and related compounds. Leaf maturity at the time of harvest also influences the composition, as does the time of year and local growing conditions. Post-harvest processing, including drying methods, exposure to light, and storage duration, can further affect the chemical profile.

Vein color, often described in consumer markets as red, green, or white, is sometimes used as a way to categorize kratom. While these labels are popular, scientific evidence shows that alkaloid concentrations vary across many factors, and vein color alone is not a reliable predictor of chemical composition.

The Regulatory and Scientific Context

In the United States, the Food and Drug Administration has not approved kratom or any of its alkaloids for any medical use. The FDA has stated that there is insufficient evidence to support the safety or effectiveness of kratom for any condition. The agency has issued public warnings, import alerts, and statements regarding kratom products. The Drug Enforcement Administration has listed kratom as a Drug of Concern but has not classified it as a controlled substance at the federal level. State and local laws vary, and some jurisdictions have placed restrictions or bans on kratom.

The World Health Organization has reviewed kratom and noted that while there is research interest in the plant, the available evidence is not sufficient for international scheduling decisions at this time.

Scientific research on kratom alkaloids is ongoing. Studies continue to explore the chemistry, metabolism, and pharmacology of mitragynine, 7-hydroxymitragynine, and the broader alkaloid family in laboratory and preclinical settings. However, much of this research is early stage, and findings from animal models or in vitro experiments do not automatically translate to human outcomes.

What Is Not Established?

It is important to be clear about what current science does not support. There are no FDA approved health claims for kratom or any of its alkaloids. Kratom should not be described as a treatment, cure, or prevention for any disease or medical condition. Statements that suggest kratom is safe, effective, or appropriate for any health purpose are not supported by approved scientific consensus and may conflict with federal regulations.

Consumers should also be aware that kratom products are not standardized in the United States. Alkaloid concentrations can vary widely between brands and even between batches from the same brand. Independent laboratory testing has found inconsistencies in product labeling and concerns about contaminants in some products.

Important Safety Considerations

Anyone considering the use of kratom should consult a qualified healthcare professional, especially if they have existing health conditions, are taking medications, are pregnant, are breastfeeding, or are under the age of 18. Kratom has been associated in some reports with adverse effects and potential interactions, and the FDA has documented case reports involving kratom. The information in this article is educational and is not a substitute for personalized medical guidance.

Frequently Asked Questions About Kratom Alkaloids

The questions below address common informational topics about the chemistry of Mitragyna speciosa. The answers are educational only and do not provide medical, legal, or product advice.

What is an alkaloid in simple terms?

An alkaloid is a naturally occurring compound, mostly produced by plants, that contains at least one nitrogen atom in its molecular structure. Alkaloids are studied across many plant species because of their distinctive chemical properties. Common examples in everyday life include caffeine, theobromine, and quinine.

How many alkaloids have been identified in kratom?

Scientific literature has identified more than 40 alkaloids in Mitragyna speciosa. The exact number reported can vary slightly between studies as analytical techniques improve and new minor compounds are documented.

What is the most abundant alkaloid in kratom?

Mitragynine is generally the most abundant alkaloid in kratom leaves. Depending on the source and growing conditions, it can represent roughly 40 to 66 percent of the total alkaloid content.

What is the difference between mitragynine and 7-hydroxymitragynine?

Mitragynine and 7-hydroxymitragynine are both indole alkaloids found in kratom, but they differ in structure and concentration. Mitragynine is the primary alkaloid by volume, while 7-hydroxymitragynine is present in much smaller amounts, often less than two percent of the total alkaloid content. The two compounds share a related core structure, but 7-hydroxymitragynine includes a hydroxyl group at the seventh carbon position.

Why do alkaloid levels vary between kratom samples?

Alkaloid concentrations are influenced by many factors, including the geographic region where the plant is grown, the maturity of the leaves at harvest, the season, climate conditions, drying and processing methods, and storage. Two samples labeled the same way can show different chemical profiles based on these variables.

Is vein color a reliable indicator of alkaloid content?

Vein color labels such as red, green, and white are common in consumer markets, but scientific research does not support the idea that vein color alone reliably predicts the alkaloid composition of kratom. Many other factors influence the chemistry of the leaf.

Are kratom alkaloids approved by the FDA?

No. The U.S. Food and Drug Administration has not approved kratom or any of its alkaloids, including mitragynine and 7-hydroxymitragynine, for any medical use. The FDA has stated that there is insufficient evidence to support the safety or effectiveness of kratom for any condition.

Is kratom a controlled substance in the United States?

At the federal level, kratom is not currently classified as a controlled substance. The Drug Enforcement Administration has listed it as a Drug of Concern. State and local laws vary, and some jurisdictions have placed restrictions or bans on kratom. Readers should check the laws that apply in their specific location.

What are the major versus minor alkaloids in kratom?

Major alkaloids are those present in the largest proportions and include mitragynine, paynantheine, speciogynine, speciociliatine, and 7-hydroxymitragynine. Minor alkaloids are present in much smaller, often trace, quantities and include compounds such as mitraphylline, corynantheidine, ajmalicine, akuammigine, tetrahydroalstonine, and many others.

What plant family does kratom belong to?

Kratom (Mitragyna speciosa) belongs to the Rubiaceae family, the same botanical family that includes coffee (Coffea species).

Where does kratom naturally grow?

Kratom is native to Southeast Asia and grows naturally in countries such as Thailand, Malaysia, Indonesia, Myanmar, and Papua New Guinea, where the climate supports its growth as a tropical evergreen tree.

Is the alkaloid content of kratom products standardized?

Kratom products sold in the United States are not standardized at the federal level. Independent laboratory testing has shown that alkaloid concentrations can vary widely across brands and even between batches from the same brand. Consumers and researchers often rely on third party lab testing for chemical analysis.

What kinds of research have been done on kratom alkaloids?

Most existing research on kratom alkaloids has been conducted in laboratory and preclinical settings, including chemical analysis, receptor binding studies, and animal models. Human clinical research is more limited. Findings from preclinical research do not automatically translate to human outcomes, and many questions remain open.

Conclusion

Kratom contains a chemically diverse profile of more than 40 identified alkaloids, ranging from the highly abundant mitragynine to trace compounds like stipulatine and speciofoline. Mitragynine, 7-hydroxymitragynine, paynantheine, speciogynine, and speciociliatine make up the most studied portion of the leaf's chemistry, while a long list of minor and trace alkaloids complete its full phytochemical signature. Understanding these compounds is useful for anyone interested in the science of the plant, but this understanding should be paired with an honest acknowledgment of the current regulatory landscape and the limits of existing research.

The chemistry of Mitragyna speciosa remains an active area of study. As analytical techniques improve and more peer reviewed research is published, scientists will continue to refine the picture of what these alkaloids are, how they vary, and what role they may play in the future of plant science.

Disclaimer

This article is for general informational and educational purposes only and is not medical or legal advice. Kratom has not been approved by the U.S. Food and Drug Administration for any medical use, and no statements in this article have been evaluated by the FDA. The information is not intended to diagnose, treat, cure, or prevent any disease or health condition. Laws regarding kratom vary by country, state, and locality, and readers are solely responsible for understanding and complying with the laws that apply where they live. While reasonable care has been taken to ensure accuracy, no warranty is made about the completeness or reliability of the content, and the author, publisher, and website disclaim any liability for any loss or damage arising from its use. Readers should consult a qualified healthcare professional or licensed attorney for personalized guidance.

 

Explore Our All Product